Stuart A. Scott
Impact in
- Pharmacology top 0.01%
- Pharmacogenetics and Drug Metabolism
- Inflammatory mediators and NSAID effects
-
- Pharmaceutical studies and practices
Papers in
- Pharmacology 65
- Pharmacogenetics and Drug Metabolism 65
- Genetics 38
- Genomics and Rare Diseases 25
- Genomic variations and chromosomal abnormalities 12
- Co-authors
- Teri E. Klein (21 shared papers)Katrin Sangkuhl (10 shared papers)Michelle Whirl‐Carrillo (19 shared papers)Robert J. Desnick (21 shared papers)Andrea Gaedigk (20 shared papers)Victoria M. Pratt (22 shared papers)Catherine M. Stein (3 shared papers)Ruth Kornreich (15 shared papers)
- Journals
- Clinical Pharmacology & Therapeutics (25 papers)Journal of Molecular Diagnostics (14 papers)Pharmacogenomics (10 papers)Clinical and Translational Science (6 papers)Genetics in Medicine (6 papers)
- Partner nations
- United StatesJapanPuerto Rico
In The Last Decade
Stuart A. Scott
144 papers receiving 9.2k citations
Stuart A. Scott's Hit Papers
Peers
Comparison fields: 5 of 138
- Pharmacology 4.4k
- Pediatrics, Perinatology and Child Health 1.4k
- Cardiology and Cardiovascular Medicine 1.3k
- Pharmacology 961
- Statistics and Probability 468
Countries citing papers authored by Stuart A. Scott
This map shows the geographic impact of Stuart A. Scott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart A. Scott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart A. Scott more than expected).
Fields of papers citing papers by Stuart A. Scott
This network shows the impact of papers produced by Stuart A. Scott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart A. Scott. The network helps show where Stuart A. Scott may publish in the future.
Co-authors
The 25 scholars most cited alongside Stuart A. Scott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 148 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update Hit paper breakdown → | 2013 | 728 |
| 2 | Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors Hit paper breakdown → | 2015 | 713 |
| 3 | Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing Hit paper breakdown → | 2011 | 513 |
| 4 | Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics‐Guided Warfarin Dosing: 2017 Update Hit paper breakdown → | 2017 | 489 |
| 5 | Standardizing Hit paper breakdown → | 2019 | 390 |
| 6 | Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC) Hit paper breakdown → | 2016 | 384 |
| 7 | Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450-2C19 (CYP2C19) Genotype and Clopidogrel Therapy Hit paper breakdown → | 2011 | 382 |
| 8 | Medical Genetics Summaries | 2012 | 324 |
| 9 | 2016 | 292 | |
| 10 | 1995 | 249 | |
| 11 | Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants Hit paper breakdown → | 2023 | 211 |
| 12 | Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing Hit paper breakdown → | 2020 | 210 |
| 13 | 2011 | 162 | |
| 14 | 2018 | 149 | |
| 15 | 2011 | 148 | |
| 16 | 2010 | 138 | |
| 17 | 2010 | 135 | |
| 18 | 2013 | 127 | |
| 19 | 2010 | 119 | |
| 20 | 2015 | 114 |
About Stuart A. Scott
Stuart A. Scott is a scholar working on Pharmacology, Genetics, Molecular Biology, Pediatrics, Perinatology and Child Health and Cardiology and Cardiovascular Medicine, having authored 148 papers that have together received 9.5k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (65 papers), Genomics and Rare Diseases (25 papers), Pharmaceutical studies and practices (23 papers), Antiplatelet Therapy and Cardiovascular Diseases (17 papers), Genomic variations and chromosomal abnormalities (12 papers), Drug Transport and Resistance Mechanisms (11 papers), Cancer Genomics and Diagnostics (9 papers) and Statistical Methods in Clinical Trials (9 papers). The work is most often cited by research in Pharmacology (4.4k citations), Pediatrics, Perinatology and Child Health (1.4k citations), Cardiology and Cardiovascular Medicine (1.3k citations), Pharmacology (961 citations) and Statistics and Probability (468 citations). Stuart A. Scott has collaborated with scholars based in United States, Japan and Puerto Rico. Frequent co-authors include Teri E. Klein, Katrin Sangkuhl, Michelle Whirl‐Carrillo, Robert J. Desnick, Andrea Gaedigk, Victoria M. Pratt, Catherine M. Stein, Ruth Kornreich, Munir Pirmohamed and D M Roden. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Journal of Molecular Diagnostics, Pharmacogenomics, Clinical and Translational Science and Genetics in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.